These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 22431611)
1. Lantibiotics from Geobacillus thermodenitrificans. Garg N; Tang W; Goto Y; Nair SK; van der Donk WA Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5241-6. PubMed ID: 22431611 [TBL] [Abstract][Full Text] [Related]
2. Geobacillin 26 - high molecular weight bacteriocin from a thermophilic bacterium. Vaičikauskaitė M; Ger M; Valius M; Maneikis A; Lastauskienė E; Kalėdienė L; Kaunietis A Int J Biol Macromol; 2019 Dec; 141():333-344. PubMed ID: 31499103 [TBL] [Abstract][Full Text] [Related]
3. Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Begley M; Cotter PD; Hill C; Ross RP Appl Environ Microbiol; 2009 Sep; 75(17):5451-60. PubMed ID: 19561184 [TBL] [Abstract][Full Text] [Related]
4. Identification of Putative Novel Class-I Lanthipeptides in Firmicutes: A Combinatorial Alkhalili RN; Canbäck B Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200662 [TBL] [Abstract][Full Text] [Related]
5. Activity of Gut-Derived Nisin-like Lantibiotics against Human Gut Pathogens and Commensals. Zhang ZJ; Wu C; Moreira R; Dorantes D; Pappas T; Sundararajan A; Lin H; Pamer EG; van der Donk WA ACS Chem Biol; 2024 Feb; 19(2):357-369. PubMed ID: 38293740 [TBL] [Abstract][Full Text] [Related]
6. Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. Dischinger J; Josten M; Szekat C; Sahl HG; Bierbaum G PLoS One; 2009 Aug; 4(8):e6788. PubMed ID: 19707558 [TBL] [Abstract][Full Text] [Related]
7. Production of a class II two-component lantibiotic of Streptococcus pneumoniae using the class I nisin synthetic machinery and leader sequence. Majchrzykiewicz JA; Lubelski J; Moll GN; Kuipers A; Bijlsma JJ; Kuipers OP; Rink R Antimicrob Agents Chemother; 2010 Apr; 54(4):1498-505. PubMed ID: 20100873 [TBL] [Abstract][Full Text] [Related]
8. NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated, and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides. Kuipers A; de Boef E; Rink R; Fekken S; Kluskens LD; Driessen AJ; Leenhouts K; Kuipers OP; Moll GN J Biol Chem; 2004 May; 279(21):22176-82. PubMed ID: 15044440 [TBL] [Abstract][Full Text] [Related]
9. Bioengineering of the model lantibiotic nisin. Field D; Cotter PD; Ross RP; Hill C Bioengineered; 2015; 6(4):187-92. PubMed ID: 25970137 [TBL] [Abstract][Full Text] [Related]
10. Characterization of amylolysin, a novel lantibiotic from Bacillus amyloliquefaciens GA1. Arguelles Arias A; Ongena M; Devreese B; Terrak M; Joris B; Fickers P PLoS One; 2013; 8(12):e83037. PubMed ID: 24349428 [TBL] [Abstract][Full Text] [Related]
11. CitA (citrate) and DcuS (C4-dicarboxylate) sensor kinases in thermophilic Geobacillus kaustophilus and Geobacillus thermodenitrificans. Graf S; Broll C; Wissig J; Strecker A; Parowatkin M; Unden G Microbiology (Reading); 2016 Jan; 162(1):127-137. PubMed ID: 26346610 [TBL] [Abstract][Full Text] [Related]
12. Nisin-A lantibiotic with immunomodulatory properties: A review. Małaczewska J; Kaczorek-Łukowska E Peptides; 2021 Mar; 137():170479. PubMed ID: 33359393 [TBL] [Abstract][Full Text] [Related]
13. Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci. Sandiford S; Upton M Antimicrob Agents Chemother; 2012 Mar; 56(3):1539-47. PubMed ID: 22155816 [TBL] [Abstract][Full Text] [Related]
14. Bacteriocin detection from whole bacteria by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Hindré T; Didelot S; Le Pennec JP; Haras D; Dufour A; Vallée-Réhel K Appl Environ Microbiol; 2003 Feb; 69(2):1051-8. PubMed ID: 12571028 [TBL] [Abstract][Full Text] [Related]
16. Bypassing lantibiotic resistance by an effective nisin derivative. Zaschke-Kriesche J; Behrmann LV; Reiners J; Lagedroste M; Gröner Y; Kalscheuer R; Smits SHJ Bioorg Med Chem; 2019 Aug; 27(15):3454-3462. PubMed ID: 31253534 [TBL] [Abstract][Full Text] [Related]
17. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens. Li Q; Montalban-Lopez M; Kuipers OP Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Peptide Production and Purification. Suda S; Field D; Barron N Methods Mol Biol; 2017; 1485():401-410. PubMed ID: 27730566 [TBL] [Abstract][Full Text] [Related]
19. Genetics of subtilin and nisin biosyntheses: biosynthesis of lantibiotics. Entian KD; de Vos WM Antonie Van Leeuwenhoek; 1996 Feb; 69(2):109-17. PubMed ID: 8775971 [TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a bioactive lantibiotic produced by Staphylococcus warneri. Petersen J; Boysen A; Fogh L; Tabermann K; Kofoed T; King A; Schrotz-King P; Hansen MC Biol Chem; 2009; 390(5-6):437-44. PubMed ID: 19361283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]